Wavelengths Explained: Red, Blue and Yellow Light

In light-based therapy, colour is not cosmetic. Different wavelengths penetrate tissue to different depths and are absorbed by different molecules, so the wavelength chosen determines the biological effect. This is one of the clearest dividing lines between a precise medical device, which controls wavelength and dose, and a consumer gadget, which generally does not. LM™ LLLT (PBM) uses defined, monochromatic wavelengths matched to the tissue being treated.

Red light

Red wavelengths penetrate relatively deeply and are well suited to the mitochondrial, energising effect at the heart of photobiomodulation. In ocular surface and eyelid applications, red light supports gland function and tissue recovery, and the 500-treatment red LLLT mask is one of the platform's principal consumables. See consumables.

Blue light

Blue wavelengths are absorbed more superficially and carry antimicrobial and anti-inflammatory properties relevant at the lid margin, where bacterial load and inflammation contribute to conditions such as blepharitis. Where available, blue and red masks are supported on the professional meibomask® for anterior-segment care.

Yellow light

Yellow wavelengths (around 590 nm) are of particular interest in the back of the eye. Yellow LM™ LLLT has been described as inhibiting VEGF expression, the signal associated with abnormal blood-vessel formation, increasing nitric-oxide signalling to reduce oxidative stress, and supporting mitochondrial ATP production in photoreceptors. These are the mechanisms behind its investigation in dry AMD.

Why selection and dose matter

The therapeutic value of any wavelength depends on delivering it at a controlled dose to the right target. Too little does nothing; an uncontrolled source is unpredictable. Espansione's devices are engineered to deliver defined wavelengths within validated parameters, which is what allows the effect to be reproduced from one patient to the next. For the underlying biology, see how photobiomodulation works.

Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.